Upload
lykhanh
View
218
Download
0
Embed Size (px)
Citation preview
DENVER OFFICE OF THE MEDICAL EXAMINER
ANNUAL REPORT 2010
DENVER OFFICE OF THE MEDICAL EXAMINER 2010 Statistical Data
PREFACE
The Coroner is an elected office pursuant to the Constitution of Colorado. State law defines the cases that are Coroner cases in Section 30‐10‐606, Colorado Revised Statutes. By the state Constitution, Denver is a combined City and County. The City and County ordinance states that the position of Coroner is to be an appointed position, chosen by the Manager of the Department of Environmental Health. These duties are entrusted to the Chief Medical Examiner. The Coroner makes all proper inquiry respecting the cause and manner of death of any of the following circumstances. 1. From external violence, unexplained cause, or under suspicious circumstances; 2. Where no physician is in attendance, or where, though in attendance, the physician is
unable to certify the cause of death; 3. From thermal, chemical or radiation injury; 4. From criminal abortion, including any situation where such abortion may have been self
induced; 5. From a disease which may be hazardous or contagious or which may constitute a threat
to the health of the general public; 6. While in the custody of law enforcement officials or while incarcerated in a public
institution; 7. When death was sudden and happened to a person who was in good health or from an
industrial accident.
Colorado Revised Statutes 30‐10‐606
CORONER – INQUIRY‐GROUNDS‐POSTMORTEM‐JURY‐CERTIFICATE OF DEATH The coroner shall immediately notify the district attorney, proceed to view the body, and make all proper inquiry respecting the cause and manner of death of any person in his jurisdiction who has died under any of the following circumstances: From external violence, unexplained cause, or under suspicious circumstances;
(a) Where no physician is in attendance or where, though in attendance, the physician is unable to certify the cause of death; (b) From thermal, chemical, or radiation injury; (c) From criminal abortion, including any situation where such abortion may have been self‐induced; (d) From a disease which may be hazardous or contagious or which may constitute a threat to the health of the general public; (e) While in the custody of law enforcement officials or while incarcerated in a public institution; (f) When the death was sudden and happened to a person who was in good health; or (g) From an industrial accident.
(1.1) After consultation with the district attorney, the coroner may request that jurisdiction of any such death be transferred to the coroner of the county in which the event which resulted in the death of the person occurred, with the jurisdiction effective upon the acceptance by the receiving coroner. Such transfer shall be in writing, and a copy thereof shall be maintained in the offices of the transferring and receiving coroners.
(1.2) When a person dies as a result of circumstances specified in subsection (1) of this section or is found dead and the cause of death is unknown, the person who discovers the death shall report it immediately to law enforcement officials or the coroner, and the coroner shall take legal custody of the body. The body of any such person shall not be removed from the place of death except upon the authority of the coroner in consultation with the district attorney or local law enforcement agency, nor shall any article on or immediately surrounding such body be disturbed until authorized by the coroner in consultation with the district attorney or local law enforcement agency.
(2) The coroner shall, if he or the district attorney deems it advisable, cause a post‐mortem examination of the body of the deceased to be made by a licensed physician to determine the cause of death.
(3) When the coroner has knowledge that any person has died under any of the circumstances specified in subsection (1) of this section, he may summon forthwith six citizens of the county to appear at a place named to hold an inquest to hear testimony and to make such inquiries as he deems appropriate.
(4) (a) In all cases where the coroner has held an investigation or inquest, the certificate of death shall be issued by the coroner or the coroner's deputy.
1. (b) Any certificate of death issued by a coroner or a coroner's deputy shall be filed with the registrar and shall state their findings concerning the nature of the disease or the manner of death, and, if from external causes, the certificate shall state whether in their opinion death was accidental, suicidal, or felonious. In addition, the certificate shall include the information described in section 25‐2‐103 (3) (b), C.R.S., whenever the subject of the investigation or inquest is under one year of age.
2. (c) A copy of the certificate of death or affidavit of presumed death, including any related documents and statements of fact, shall be retained in the applicable county in a secure location in an appropriate county facility accessible only to the county coroner or the coroner's designee and in a manner that is consistent with the county's record retention policy and federal law.
(5) Nothing in this section shall be construed to require an investigation, autopsy, or inquest in any case where death occurred without medical attendance solely because the deceased was under treatment by prayer or spiritual means alone in accordance with the tenets and practices of a well‐recognized church or religious denomination.
(6) (a) Notwithstanding the provisions of sections 12‐43‐218 and 13‐90‐107 (1) (d) or (1) (g), C.R.S., the coroner holding an inquest or investigation pursuant to this section has the authority to request and receive a copy of: (I) Any autopsy report or medical information from any pathologist, physician, dentist, hospital, or health care provider or institution if such report or information is relevant to the inquest or investigation; and
3. (II) Any information, record, or report related to treatment, consultation, counseling, or therapy services from any licensed psychologist, professional counselor, marriage and family therapist, social worker, addiction counselor, or unlicensed psychotherapist if such report, record, or information is relevant to the inquest or investigation.
4. (b) The coroner shall, at the request of the district attorney or attorney general, release to the district attorney or attorney general any autopsy report or medical information described in subparagraph (I) of paragraph (a) of this subsection (6) that the coroner obtains pursuant to paragraph (a) of this subsection (6).
5. (c) The coroner shall not release to any party any information, record, or report described in subparagraph (II) of paragraph (a) of this subsection (6) that the coroner obtains pursuant to paragraph (a) of this subsection (6).
6. (d) Any person who complies with a request from a coroner pursuant to paragraph (a) of this subsection (6) shall be immune from any civil or criminal liability that might otherwise be incurred or imposed with respect to the disclosure of confidential patient or client information.
Mission Statement The Denver Office of the Medical Examiner, as a guardian of the health, safety, and welfare of our community, constantly strives toward the goal of a safer and healthier Denver. The office appreciates the support and cooperation received from the citizens of Denver and welcomes comments and suggestions. Questions, comments or suggestions may be directed to this office at our web site. Office of the Medical Examiner Comments and Suggestions 660 Bannock Street [email protected] Denver, CO 80204 303‐436‐7711
2010 Budget Org Chart Office of the Medical Examiner
23 FTE
Chief Medical Examiner/Coroner 1 FTE
Amy Martin, MD
Manager 2, 1 FTE Michelle Weiss-Samaras
Forensic Pathology Fellow, 1 FTE Michael Burson, MD (June 30, 2009)
Joe White (July 1, 2010)
Forensic Pathologist, 2 FTE James Wahe, MD John Carver, MD
Medical Transcriptionist, 2 FTE Glenda Slade Jami Milsap
Administrative Support Supervisor I, 1 FTE
Roberta (Kathy) Blea Coroner Investigator Supervisor,
1 FTE Don Bell
Forensic Autopsy Technician Supervisor, 1 FTE Karen Jazowski
Admin III, 3 FTE Monica Sandoval, Cecelia Albertson, Galena Brown
Coroner Investigator, 7 FTE Ginger Jones, Tracey Balbin-
Montano, Kerrie Cady, Harris Neil, Howard Daniel, Justin Earls, TC
Whitley
CI Duties: Investigate deaths (including scene response), oversee
custody and disposition of medications and evidence, locate and notify next of kin, coordinate
identification activities
Forensic Autopsy Technician, 3 FTE
Barb Criter, Esperanza Ortega, Robert Garner
Duties: Assist performance of autopsies, take x-rays, maintain
autopsy area, evidence and effect handling
Duties: Purchasing, release bodies and effects, prepare official
documents (e.g. death certificates), case reporting (DAWN)
Duties: Oversees investigative activities, coordinates emergency preparedness planning
Duties: Oversees and supports autopsy room operations, perform
autopsy technician duties
Duties: Oversees and support front clerical
staff: supportive role in budget, purchasing, case
reporting (CVDR)
Duties: Transcribe pathology reports, send out tests and reports,
data entry
Duties: Cause and manner of death certification, postmortem exams,
expert testimony, teaching
Duties: Forensic pathology trainees
Duties: Chief Deputy Coroner, Media Liaison, Budget and Director of Administrative and
Investigative Sections. Oversees overall administration and investigative functions
Duties: Division Director, forensic pathologist duties, Program Director
for fellow, Community liaison
On August 27, 1947, the Denver Coroner’s Office hired its first Medical Examiner. Dr. Angelo Lapi was a 34‐year‐old assistant Medical Examiner for Massachusetts. He was a graduate of the medical school of the University of Buffalo, a pathologist and research fellow of the Department of Legal Medicine in Harvard. He was approved to start on October 1, 1947, at the monthly salary of $666.00. The assistant Medical Examiner at that time was Dr. George Ogura (who later retired in the late 1980’s as the Chief Forensic Pathologist). The State Constitution requires every county to have a coroner. On August 25, 1947, City Council approved the appointment of the Manager of Health and Charity to be the ex‐officio coroner. At that time, the coroner inquests were stopped in the City and County of Denver. The office separated from Denver Health Medical Center (previously known as Denver General Hospital) in 1997, and joined the newly developed Department of Environmental Health for the City and County of Denver. During years past, this office had the pleasure to have many well known forensic pathologists as a part of the team. Dr. George I. Ogura, Dr. Henry Toll, Dr. Ben Miyahara, Dr. Donald Clark, Dr. Ben Galloway, Dr. James Wahe, Dr. Amy Martin, and Dr. Thomas Henry, and many successful pathology residents and forensic fellows through the years who continue to practice forensic pathology throughout the country. Dr. Amy Martin became the Chief Medical Examiner on December 14, 2007. She is appointed as the Coroner by the Manager of the Department of Environmental Health per City Ordinance § 2.12.2
DENVER OFFICE OF THE MEDICAL EXAMINER STAFF 2010
AMY MARTIN, M.D. CHIEF MEDICAL EXAMINER
CORONER
MICHELLE D. WEISS‐SAMARAS CHIEF DEPUTY CORONER
JAMES W. WAHE, M.D.
ASSISTANT MEDICAL EXAMINER
JOHN D. CARVER, MD., J.D. ASSISTANT MEDICAL EXAMINER
FORENSIC PATHOLOGY FELLOWSHIP
In 2008, OME received Accreditation Council for Graduate Medical Education accreditation for a forensic pathology fellowship sponsored by the University Of Colorado Denver School Of Medicine. In July 2009, the program’s first forensic pathology fellow began a one‐year period of training in the area of forensic
pathology. This program is designed to prepare forensic pathologists for Board certification and practice in the field of forensic pathology.
2009 – 2010 Forensic Pathology Fellow Michael Burson, M.D., Ph.D.
2010‐2011 Forensic Pathology Fellow Joseph K. White D.O.
DENVER OFFICE OF THE MEDICAL EXAMINER INVESTIGATIVE STAFF 2010
Donald Bell, Coroner Investigator Supervisor INVESTIGATORS
Tracey Balbin‐MontanoHoward DanielJustin EarlsKerrie Cady
Genevieve JonesHarris NeilT.C. Whitley
INVESTIGATIONS SECTION The Investigations Section responds to the scenes of deaths throughout the City and County of Denver twenty‐four hours a day, seven days a week. It is the responsibility of the Coroner Investigator to function as the eyes and ears of the Medical Examiner and insure that the State law is followed with respect to the reporting and handling of deaths in Denver City and County. The investigators also investigate hospital, nursing homes and other facility deaths that fall under the Coroner statute. They are responsible for identification of the decedent, locating and notification of the next of kin and processing some of the evidence, medication, and effects of the decedent.
OME investigators respond to any death scene where the body has not been removed if the death occurs outside of a healthcare facility. Investigators may also respond to select hospital deaths; for example many homicides and child deaths where the individual has been transported to an emergency room. Investigators may also respond to a hospital or healthcare facility if the death appears due to non‐natural circumstances (a suicidal hanging that occurs in a psychiatric unit). Again, there can be a great deal of month‐to‐month fluctuation in the number of scenes although overall the number does not vary greatly and generally averages between 60 and 70 scenes per month. 2009 saw a slight decrease overall as a trend, although 2010 saw a slight increase trend in scenes.
2009 vs. 2010 scene visits
0102030405060708090
100
Num
ber
2009 66 68 87 80 65 47 45 68 62 63 77 622010 71 51 56 57 69 45 51 49 66 82 63 60
Jan Feb March April May June July Aug Sept Oct Nov Dec
DENVER OFFICE OF THE MEDICAL EXAMINER FORENSIC AUTOPSY TECHNICIAN STAFF 2010
Karen Jazowski, Forensic Autopsy Technician Supervisor Forensic Autopsy Technicians
Barbara Criter Robert Garner
Esperanza Ortega
This section is responsible for providing direct support in the autopsy room to the Assistant Medical Examiners and the Chief Medical Examiner. Staff duties include but are not limited to, preparation of the bodies for autopsy, assisting the medical examiners in the performance of the autopsy, assisting in collection and storage of toxicological specimens, performing post mortem x‐rays, performing some forensic photography and releasing bodies to the mortuary. This section is also responsible for fingerprinting of the decedent.
DENVER OFFICE OF THE MEDICAL EXAMINER ADMINISTRATIVE STAFF 2010
Roberta (Kathy) Blea, Administrative Support Supervisor I ADMINISTRATIVE STAFF
Galena Brown Monica Sandoval Cecelia Albertson
MEDICAL TRANSCRIBERS Jami Milsap Glenda Slade
These sections are responsible for providing administrative support to all members of the staff. Administrative staff duties include customer service, releasing remains, finalizing death certificates, billing and bookkeeping, and processing personal effects. Transcription duties include transcribing autopsy reports, fulfilling report requests, and sending out laboratory samples for analysis.
INVESTIGATIVE INTERNSHIP PROGRAM OME offers a one‐year medicolegal investigative internship program with the following schools: University of Denver Graduate Program – Masters of Forensic Psychology, Metropolitan State College and the University of Colorado, Denver Campus. Undergraduate seniors and graduate students compete to participate in a program designed to train forensic death investigators. During the internship year, interns are expected to carry their own case load that includes gathering of information for the determination of the cause and manner of death, assisting in identification of the decedent, investigating cause and manner of death, assist in the identification of the decedent, assist in locating and notifying next of kin, and proper documentation of a death scene. Upon successful completion, participants are eligible for certification as a medicolegal death investigator by the Colorado Coroner’s Association. The program also prepares participants for eventual ABMDI (American Board of Medicolegal Death Investigation) accreditation after hire in a coroner or medical examiner’s office.
FORENSIC AUTOPSY TECHNICIAN INTERNSHIP PROGRAM OME offers numerous Autopsy Technician internships with the following schools: University of Colorado Experiential Learning Center, Metropolitan State College at Denver, Regis University, Denver, and Wesleyan University in Nebraska, Masters in Forensic Science. With the exception of Wesleyan University, which offers a two‐week rotation, participants are offered a one‐semester internship. During this internship, participants work closely with staff pathologists and Autopsy Technicians in the autopsy room, and gain experience in clinicopathologic correlation, forensic photography, fingerprinting, and evidence collection.
DENVER OFFICE OF THE MEDICAL EXAMINER INTERN STAFF 2010
Forensic Autopsy Internship Program – 3 month internship
Kim Johnson Colorado University BoulderGraduate Anthropology, History, & Russian Studies
Josh Kniss Regis University Neuroscience and Psychology minor exercise science
Elizabeth Empey University of Colorado Denver Biology Chemistry Pre‐med
Connie McCormack Metropolitan State CollegeBiology Major
Tori Perry Metropolitan State College Biology Major
Coroner Investigative Internship Program – One Year Internship
Lara Ward 2009‐2010 University of Colorado at Denver Bachelors Criminal Justice and Sociology
Alex Raxumovski 2009‐2010 University of Colorado at Denver Bachelors Criminal Justice minor Sociology
Justin Stiebel 2009‐2011 University of DenverGraduate School Forensic Psychology
Ashley Anne Peightal
2010‐2011 University of DenverGraduate School Forensic Psychology
Katie Nilsson 2009‐2010 University of Colorado at Denver Graduate School Masters Criminal Justice
Kate Makkai 2009‐2010 University of Colorado at Denver Bachelors Forensic Anthropology
Melanie Gutteau 2010‐2011 Metropolitan State College Bachelors Criminal Justice
Kayla Wallace 2010‐2011 University of Denver Graduate School Forensic Psychology
Andrea Raffaut 2010‐2011 University of Denver Graduate School Forensic Psychology
Stacy Salmon 2009‐2011 University of Colorado at Denver Graduate School Masters Criminal Justice
Amanda Sapir 2009‐2010 University of Colorado at Denver Bachelors Anthropology
Wesleyan Nebraska ‐ Two Week Site Visit Antoni Stewart Masters program Forensic Science Michael O’Brien Masters program Forensic ScienceJonna Grooman Masters program Forensic ScienceKristin Wiesneski Masters program Forensic Science
SCHOLARLY ACTIVITIES The Denver Office of the Medical Examiner participates in a wide variety of community education through affiliations with area universities, as well as community outreach activities throughout the Denver Metropolitan area with high schools and middle schools, medical providers, and other interested parties.
UNVERSITY OF COLORADO SCHOOL OF MEDICINE
Two of the three forensic pathology staff has official academic appointments with the University Of Colorado School Of Medicine through the Department of Pathology. All staff pathologists participate in the education of medical students in both general pathology as well as forensic pathology and participate in clinicopathologic laboratories. In addition, medical students have the opportunity to rotate through the Office of the Medical Examiner for credit, gaining firsthand knowledge of the area of forensic medicine. Pathology residents at the University of Colorado have a one‐month rotation offered in the third or fourth year. During this rotation, pathology residents gain practical experience in the performance of the forensic autopsy, and also have the opportunity to respond with medicolegal death investigators and, when applicable, staff pathologists to death scenes. Whenever possible, residents are encouraged to accompany staff pathologists to observe courtroom testimony. OME pathologists have partnered with forensic pathologists in the Arapahoe County Coroner’s Office, as well as Dr. Geza Bodor, Director of the Chemistry and Molecular Laboratories at the Veterans’ Affairs Medical Center, to offer pathology residents a series of lectures, given over the course of two years, in a wide range of forensic and toxicologic topics.
MASS FATALITY RESPONSE In March 2006, the Denver Office of the Medical Examiner Chief of Investigations spearheaded the establishment of the North Central Region Mass Fatalities Committee. This multi‐county group was formally accepted as a joint Denver Urban Area Initiative/ North Central Region committee. The committee has drafted a regional mass fatalities plan and meets monthly to further prepare for a mass fatalities incident. The investigative unit remains very active with this organization.
RESERVE CORPS
In September 2008 the Investigative section of the Denver Office of the Medical Examiner established a reserve corps. This pool of volunteers was established to train volunteers for duty in the event of a mass fatality incident. The corps received periodic forensic training as well as experience in death scene investigations.
COHEART In Nov 2009 the North Central Region Mass Fatalities Committee was awarded a $57,000 grant by the Denver Urban Area Security Initiative to establish and train a COlorado Human Remains Extraction and Recovery Team (COHEART). The grant provides for equipment and training of up to 77 volunteers to conduct remains recovery in the event of a mass fatality incident, and builds on the Denver Office of the Medical Examiner Reserve Corps. Volunteers are recruited from prior interns, medical personnel, prior law enforcement and Coroner staff members. All volunteers are screened and have background checks. The volunteers must participate in training throughout the year, spend time with the investigators and observe autopsies.
Cheesman Park Irrigation System Upgrade In 2010, Cheesman Park in central Denver upgraded its irrigation system. Like the Botanic Gardens, Cheesman Park also was built on top of an historical cemetery. During excavation, several historical graves were uncovered. Many of the human bones represented only partial skeletons, but at least three virtually complete skeletons were uncovered along with several other fairly complete skeletons. OME partnered with Dr. Cathy Gaither, Assistant Professor of Anthropology at Metropolitan State College of Denver to study and document the remains prior to re‐interment at Mount Olivet Cemetery. This was a unique experience for Dr. Gaither's students as well as for OME staff.
COMMUNITY OUTREACH
OME participates in a wide range of community outreach activities over and above education, along with other public health activities. Examples include: regional mass fatality planning, both state and local child fatality review, maternal fatality review, the Governor’s Expert Emergency Response Council (GEERC), Denver Epidemiology Work Group (DEWG) through the Denver Office of Drug Strategy, and the Metro Area County Coroners and Medical Examiners (MACCME).
o The various fatality review committees, through case study and examination of collected data, try to determine trends and patterns in the factors that cause and contribute to death, and ultimately try to develop strategies to reduce or prevent future deaths.
o The MACCME is a forum whereby the Metro Area Coroners can regularly discuss
common issues and develop strategies to address these issues. Some examples include partnering with Front Range Community College to develop a certificate program in death investigation and developing a standardized protocol for reporting child deaths to the metro‐area coroners with The Children’s Hospital.
o The GEERC (Governor’s Expert Emergency Response Council)
The Denver Office of the Medical Examiner is represented by a staff member on the GEERC which consists of businessmen, physicians, public health officials, hospital administrators, pharmacists, American Medical Association, veterinarians, coroners, funeral directors, lawyers, Better Business Bureau, and vital statistics personnel. The Council serves to: 1) strategize state response to a disaster or epidemic, 2) oversee distribution of money and supplies (vaccines) statewide, and propose laws and regulations, 3) promote education and information distribution concerning epidemics and natural disasters, 4) evaluate the effectiveness of the State’s responses to the Governor and to the organizations represented.
o The DEWG (Denver Epidemiology Work Group) was formed in 2008 through the
Denver Office Of Drug Strategy. Modeled after the National Institute on Drug Abuse’s Community Epidemiology Work Group, he DEWG provides ongoing community‐level surveillance of alcohol and drug abuse in the Denver Metropolitan area through analysis of quantitative and qualitative data regarding drug and alcohol abuse trends and populations. Participates include representatives from law enforcement; prevention, intervention and treatment programs, medical facilities, toxicology, OME, and public health.
o The Coroner Resource Committee of Donor Alliance was formed to improve communication between the organ and tissue procurement agencies and the coroners. All metro area coroners and representatives from DA and the Rocky Mountain Lions Eye Bank meet several times a year to discuss recovery statistics and issues that may have arisen.
In addition to their usual duties, the Chief Deputy, Chief Investigator and coroner investigators frequently lecture at local high schools, hospitals, local organizations, law enforcement, as well as Denver colleges and universities. They participate in local job fairs and career day events. They are involved in the training of new victim advocates in Colorado. The pathologists also lecture to various agencies, health care providers, law enforcement, and coroners.
It's
COMMUNITY SERVICE
Red Rocks Community College – Michelle Weiss‐
Samaras and Donald Bell Regis University Criminal Justice & fraternal forensic organization – Donald Bell Coalition for the Homeless and Department of Health and Human Services – Michelle Weiss‐Samaras Colorado Hospice training, Victim Advocate training, and Denver Hospital In‐Service Training ‐ Michelle Weiss‐Samaras Denver Police Department Victim Advocate Ride along program – Investigative Section (Inv. Daniels, Cady, Jones, Neil, Whitley, Earls, and Montano) NCRFMC (North Central Region Fatality Management Committee ‐ 10 county region) ‐ Tracey Montano and Donald Bell Denver International Airport – Disaster preparation – Michelle D. Weiss‐Samaras and Donald Bell In June 2010, the Denver Office of the Medical Examiner hosted the FEMA course Mass Fatality Incident Response. The target audience of COHEART members numbered 38. University of Colorado Community Project for Alumni and Students – Tracey Montano Media Liaison – Michelle Weiss‐Samaras Tours/lectures out of state – Nebraska and Wyoming Colleges – Michelle D. Weiss‐Samaras & Don Bell
Disaster Mortuary Operational Response Team (DMORT) – Karen Jazowski Denver Child Fatality Review, Colorado Maternal Fatality Review, DEWG, MACCME, Coroner Resource Committee, National Association Medical Examiner Ad hoc Self Assessment Module Committee – Dr. Amy Martin Denver Center for Crime Victims In‐service ‐ Investigative Section (Inv. Daniels, Cady, Jones, Neil, Whitley, Earls, and Montano) Southern Institute of Forensic Science Lecture – Tracy Montano Upward Bound Math and Science Imitative – Casper Wyoming – Don Bell Local Middle & High School lectures – metro area – Michelle Weiss‐Samaras and Don Bell University of Colorado Pathology Residents Liaison – Dr. James Wahe Notary Public Training – Galena Brown Recycle Ink Program – Glenda Slade Green Recycle – DOME staff INTERDEPARTMENTAL COMMITTEES DEH Safety Committee – James Wahe M.D. Performance Evaluation Review Committee – Karen Jazowski Employee Recognition Committee – Cecilia Albertson
OFFICIAL COMMITTEE APPOINTMENTS
Colorado Child Fatality Prevention Review Team ‐ Dr. Amy Martin, Governor Appointee
Advisory Board for the Career Technological Education Program,
Montbello High School ‐ Michelle Weiss‐Samaras
Governor’s Expert Emergency Response Council – Dr. James Wahe, Alternate
PROFESSIONAL ORGANIZATIONS AND AFFILIATIONS
Colorado Coroner's Association – DOME Staff
American Academy of Forensic Sciences – Amy Martin, M.D. James Wahe M.D.
National Association of Medical
Examiners – Amy Martin M.D., John Carver M.D., JD, James Wahe M.D.
American Board of Medicolegal Death Investigators – Investigators Howard Daniel, Harris Neil, Genevieve Jones, Donald Bell, Tracey Balbin‐Montano, Justin Earls
Colorado Organization of Victim Assistance – Michelle Weiss‐Samaras
American Medical Association – Amy Martin M.D.
College of American Pathologists – Amy Martin M.D.
American Society for Clinical Pathology – Amy Martin M.D. and
John Carver M.D., JD
Colorado Society of Clinical Pathologists – Amy Martin M.D.
VICTIM ADVOCATES AND FAMILY ASSISTANCE
While there are no Colorado state laws which require the Coroner/Medical Examiner to identify and locate next of kin, this office has historically been tasked with this job. The Medical Examiner’s Office is fortunate to have the assistance of the Denver Police Department Victim Advocates to assist when possible in the notification of the next of kin. The interaction between the two offices has proved to be invaluable.
ORGAN/TISSUE/CORNEAL RECOVERY OME supports organ and tissue recovery whenever possible, and works closely with local procurement agencies such as Donor Alliance and the Rocky Mountain Lions Eye Bank to facilitate recovery activities in response to the large need for both organs and tissues on a local, as well as a national level. OME follows the Colorado Organ and Tissue Donation Coroner Protocol, which is an agreement signed by the Coroners and the District Attorney for each participating county along with Donor Alliance and the Rocky Mountain Lions Eye Bank. This protocol is designed to optimize organ and tissue recovery through cooperation and communication between all signed parties. Local coroners meet with representatives from the procurement agencies on a regular basis to review the protocol and update as needed. In addition, the Coroner Resource Committee, made up, again, of representatives from the organ and tissue procurement agencies as well as the metro areas coroners, meets between two and four times a year. These meetings have proven invaluable in addressing any concerns local coroners may have with organ and tissue recovery, as well as address specific problems that may have arisen on a case‐by‐case basis. These meetings also allow the procurement agencies to keep coroners informed of the changing requirements and technologies that they may have as recovery techniques change and donation needs evolve. INFORMATION SHARING Colorado Violent Death Reporting System The Denver Office of the Medical Examiner compiles data on all violent deaths in the county which is then used by the Centers for Disease Control and Prevention (CDC). This grant funded program housed at Colorado Department of Public Health and Environment (CDPHE) has provided a better understanding of the drivers and risk factors associated with violent deaths. Thirteen states including Colorado participate in the National Violent Death Reporting System (NVDRS). The data collection began with cases from January 2004 to date. More information on the program is available at www.cdc.gov/ncipc/dvp/dvp.htm Drug Abuse Warning Network (DAWN) The Denver Office of the Medical Examiner also provides statistical data to DAWN, and is one of the six counties in Colorado participating. Various community statistical reports The Denver Office of the Medical Examiner assists agencies such as the media, human services, and the Coalition for the Homeless with regularly distributed reports on homeless and homicide deaths.
ACADEMIC PRESENTATIONS American Academy of Forensic Sciences 2010 Meeting Seattle, Washington, Poster presentation Dr. Michael Burson was the lead investigator in a project the studied the stability of Vitamin D in postmortem blood samples. The results were accepted as a poster presentation at the 2010 Annual Meeting of the AAFS. Postmortem vitamin D levels may be useful in working up potential child abuse deaths where one or more fractures are present.
Objective: To measure vitamin D in postmortem blood samples using our recently developed liquid chromatography-tandemmass spectrometric (LCMSMS) method. Our current method provides for measurement of the 25-hydroxy derivatives of vitaminD, specifically 25(OH)-D2/D3, (OHD2, OHD3) in human serum. Increasingly, current clinical practice is to measure OHD2 andOHD3 to assess vitamin D nutritional status. To our knowledge, methods have not been evaluated for measuring these analytes inpostmortem samples. The most common assay platform used today is an immunobased assay, which relies on antibodies whichare known to cross-react with many vitamin D metabolites. Such immunobased assays are particularly sensitive to sampleintegrity and it is likely that a postmortem blood sample may not be appropriate due to hemolysis and other postmortem artifacts.Hypothesis: Postmortem (PM) vitamin D concentration, measured with a sensitive and specific assay such as LC-MSMS, willcorrelate well with antemortem (AM) concentrations. Such analysis will be helpful in those cases where antemortem vitamin Dlevels have not been previously measured in the primary care setting. Furthermore, with the recent interest in vitamin Ddeficiency (Rickets) and multiple bone fractures in pediatric deaths, such an assay will, without doubt be of interest.Materials and Methods: For our preliminary studies we selected three recent cases of natural disease. In each case, we sampledperipheral blood (iliac vein) within 24 hours of the time of pronouncement. Approximately 8 ml of peripheral blood was drawninto a red-top tube under gentle pressure to minimize hemolysis. Each sample was allowed to clot at room temperature for 1 hourand then centrifuged for 25 minutes. The serum was then transferred to a clean red-top tube and frozen at -20 C until assayed.Hexa-deuterated OHD2 and OHD3 (OHD2d6 and OHD3d6, Medical Isotopes, Inc.) were used as internal standards (IS).Calibrators were prepared in albumin at 5, 10, 20, 50, 100 and 150 ng/ml for each analyte (OHD2 and OHD3). Samples andcalibrators (500 ul) were spiked with 75 ng IS, extracted in 1 ml ACN and centrifuged. Thirty ul of supernatant was injected into aShimadzu HPLC (70% H2O:30% ACN) at an initial flow rate of 350 ul/min flow and increased to a maximal flow rate of 500ul/min. OHD2 and OHD3 were separated on a C18 column (100 mm x 2.1 mm x 3 um, RESTEK) and then introduced into atriple quadrupole mass spectrometer (ABI 3200 Q-trap) via an APCI source in the positive ion mode. OHD2 and OHD3 wereeluted at 100% ACN over a 9.7 minute run.Results: Preliminary studies addressed whether or not vitamin D analytes are stable in postmortem blood and if so whether theycan be measured with our LC-MSMS method. In each of the samples tested to date, we have successfully and reproduciblydetected and quantitated total vitamin D (OH-D3) in levels ranging from 6.43 ng/ml to 95.3 ng/ml. We are confident in theseresults because we have previously established the level of quantitation (LOQ) of our assay at 5 ng/ml.Summary: We have shown that postmortem blood contains measurable vitamin D and can be accurately measured on our LC-MSMS platform. Our immediate planned studies on adult and pediatric cases include: (1) a direct comparison of hospitaladmission antemortem blood with our 24 hr postmortem blood samples; (2) a direct comparison of plasma and serum samples; (3)a postmortem stability assay to characterize how the postmortem interval affects our ability to accurately measure vitamin D.
Michael A. Burson MD, PhD1,2, John Carver, MD1,2 Jim Wahe, MD1,2, Amy Martin, MD1,2 , Jennifer Puhl3, Geza S. Bodor MD1,3
1University of Colorado Denver, Department of Pathology, Aurora, CO; 2Denver Office of the Medical Examiner, Denver, CO; 3Denver VA Hospital, Denver, CO
Postmortem analysis of vitamin D using liquid chromatography tandem mass spectrometry
I. Using LC-MS/MS methodology, vitamin D (OH-D3) is accurately and reproducibly measurable in postmortem bloodsamples
II. Postmortem OH-D3 levels appear to correlate well with antemortem levels regardless of the type of collection tubewith the exception of Na-Citrate (data not shown)
III. OHD3 is extremely stable (up to 7 days) and thus it is likely that it may be accurately measured several days after theterminal event
IV. Although one outlier is observed (Case 2789), postmortem redistribution of OH-D3 does not appear be significant;thus the sample collection site may not be a limiting factor in those cases where postmortem blood may be limited(pediatric)
V. The clinical encounter must be considered when interpreting postmortem OH-D3 levels because the patient may havebeen fluid resuscitated and/or transfused with blood products.
VI. OH-D2 metabolite was not found in any of our cases therefore its postmortem behavior could not be assessed. Theabsence of OH-D2 in AM or PM samples is not unexpected as it is present in only found in only 15% of all individuals.
References:1. Holik MF (2007) Vitamin D Deficiency. N Engl J Med 357:266-2812. Suskind D (2009) Nutritional Deficiencies During Normal Growth. Ped Clin N Am 56:1035-1053.3. Gordan C et al (2004) Prevalence of vitamin D deficiency among healthy adolescents. Arch Ped Adol Med 158:531-537.
Discussion
Results
Abstract
Qa
ObjectivesOur primary objective is to determine the feasibility and utility of measuring vitamin D in postmortem blood samples. To address this question we’ve outlined four main objectives for this study:
I. To determine if vitamin D is measurable in postmortem blood samples.
II. To determine if postmortem vitamin D level accurately reflects the antemortem level
III. To characterize any postmortem redistribution of vitamin DIV. To characterize the stability of vitamin D in postmortem blood
under “uncontrolled” conditions (room temperature + UV light
Materials and MethodsSample preparation:Postmortem peripheral blood (iliac vein) was collected within 24 hours of the time of pronouncement. Approximately 8 mlof whole blood was collected into a glass, additive free red-top tube and allowed to clot at room temperature for 1 hourand then centrifuged for 25 minutes. The serum was then transferred to a clean red-top tube and frozen at -20 C untilassayed. Hexa-deuterated OHD2 and OHD3 (OHD2d6 and OHD3d6, Medical Isotopes, Inc.) were used as internalstandards (IS). Calibrators were prepared in 3% albumin at 5, 10, 20, 50, 100 and 150 ng/ml for each analyte (OHD2 andOHD3). Samples and calibrators (500 ul) were spiked with 75 ng IS, extracted in 1 ml ACN and centrifuged. Thirty ul ofsupernatant was injected into a Shimadzu HPLC (70% H2O:30% ACN) at an initial flow rate of 350 ul/min flow andincreased to a maximal flow rate of 500 ul/min. Analytes were separated on a C18 column (100 mm x 2.1 mm x 3 um,RESTEK) and then introduced into a triple quadrupole mass spectrometer (ABI 3200 Q-trap) via an APCI source in thepositive ion mode. OHD2 and OHD3 were eluted at 95% ACN over a 9.7 minute run.Data analysis:AM vs. PM study: Samples were injected as duplicates and the results were averaged and expressed as ng/ml.
Redistribution study: PM whole blood (2ml) was collected from the iliac vein (IV), iliac artery (IA; when available), rightatrium (RA) and aorta (Ao). Samples were injected in duplicate and the results were averaged and expressed as ng/ml.
Stability study: Postmortem whole blood from the IV was collected and allowed to set at room temperature and exposed toultraviolet light for up to seven days (T=0-7 days). Each sample was injected in duplicate and then averaged. The IV[OH-D3] was set at 100% and the remaining sites were normalized to this and the results were expressed at % recovery.Linear regression analysis was performed and the results are expressed with -/+ 2SD.
**Low AM level may representResuscitation related dilution
*PM aorta sample was QNS to repeat. This level is likely an artifact.
Introduction
Case Age Race COD MOD
61 49 C Peritonitis N
79 41 C Arrrythmia H
80 41 AA Hanging S
1744 58 H BFI Head A
1855 42 C Heroin A
1944 30 H Hanging S
1975 34 AA Undet. U
2765 57 W C/O EtOH N
2778 63 W GSW S
2789 34 W GSW S
2802 55 W ASCVD N
2806 28 W BFI A
2892 16 W Drug Tox A
2945 12 W Hanging S
Vitamin D is a prohormone that is essential for normal calcium homeostasis and bonedevelopment. Deficiency in vitamin D leads to hypocalcemia and hypophosphatemia, withresultant rickets in children and osteomalacia in adults (1-2). In adults, vitamin D deficiencyhas been linked to cardiovascular disease, insulin resistance, hypertension and otherconditions. With the well-documented worldwide prevalence of vitamin D deficiency in allages it is likely that the forensic community will encounter cases in which knowing vitamin Dlevels may be pertinent to determining the cause and manner of death. It has been reportedthat approximately 50% of Caucasian and non-Caucasian adolescents have vitamin D levelsless than 20ng/ml (3). Current guidelines set vitamin D deficiency at <20 ng/ml and vitaminD insufficiency at <30 ng/ml. . Unfortunately, to date there are no reported studies of vitaminD levels in postmortem blood. Herein, we report the results of our study on postmortemvitamin D analysis.
**
*
This work built on previous work done by Dr. Burson during pathology residency at the University of Colorado School of Medicine and presented at the American Association for Clinical Chemistry in Anaheim, CA.
Objective: There is contradictory information regarding vitamin D (VitD) stability in human blood.Our lab used to require collection and transport of samples in dark tubes and storage below –20 C untiltesting. To eliminate the need for these error prone practices we evaluated VitD stability at ambient,refrigerated and frozen temperatures, using no additive (red top, RTT) and gel separator (SST)collection tubes. We also investigated the effect of hemolysis and exposure to fluorescent light on VitDconcentration during storage. Methods: Our in-house LC-MSMS VitD assay uses a Shimadzu binaryHPLC system and AB3200 Q-Trap triple-quadrupole mass spectrometer. 25-OH vitamin D2 (OHD2),25-OH vitamin D3 (OHD3), parent vitamins D2 and D3 and their respective hexa-deuterated internalstandards are separated on a C18 column following protein precipitation. MS analysis is performedusing APCI positive ionization. Run time is 9.7 minutes. Assay measuring range is 5 to 150 ng/mL foreach analyte. Total imprecision is 7% to 11% throughout the AMR range. We used left over serum, orserum from volunteers for our study. Fresh serum was kept at ambient temperature, under fluorescentlight on the bench for up to 24 hours to assess short-term stability. Aliquots were taken at 3, 6, and 24hours and frozen until assayed. Long-term stability of VitD was assessed by comparing result of fresh(T0) samples from RTT to that of the SST serum. Centrifuged samples were left in the SST tubes at 4C for up to 19 days to determine potential absorption of VitD by the gel. Frozen stability was assessedby re-assaying left over samples, kept below –20C for as long as sufficient amount of serum wasavailable for testing. We added increasing amounts of hemolyzed RBC to pooled sera to assessinterference from hemolysis. Each sample was assayed twice. Samples from the short-term stabilityand hemolysis interference studies were analyzed within the same run. Samples from the long-termstability study were extracted and assayed in separate runs, on days when VitD testing was performed.Results: OHD3 concentrations in samples of the short-term study ranged from 5 to 60 ng/mL. Allresults from T0 to T24 hours were within the 2SD range of our method. No statistical differencebetween time points and no trend could be detected within 24 hours of storage. No significantdifference between OHD3 result of RTT and SST serum could be detected at T0. All results from latertime were within assay imprecision. No difference between RTT and SST was found for up to 19 daysbut a slight upward trend in concentration could be observed. Hemolysis (up to 1.2 g/dL hemoglobin)had no effect on VitD concentration. Frozen samples were stable for at least six months. We couldascertain OHD3 stability only because none of the samples contained OHD2.
Michael A. Burson MD, PhD1,3, Jennifer Puhl2 , Geza Bodor MD1,21University of Colorado Denver, Department of Pathology, Aurora, CO; 2Denver VA Hospital, Denver, CO ; 3Denver Office of the Medical Examiner, Denver, CO
25-OH vitamin D is stable in the clinical setting under many different collection and storage conditions
Discussion
Results
Abstract
Q a
Materials and Methods
Ambient conditions stability: Serum was collected in red top tube from 24 volunteers and the tubes were allowed to set at room temperaturewhile exposed to fluorescent light for up to 24 hours. Aliquots were taken at T=0, 3, 6 and 24 hours and frozen until assayed. Each sample wasinjected in duplicate and the results averaged. The concentration at T=0 was assigned 100% and recoveries at the remaining time points werenormalized to this. Results were expressed as % recovery. Linear regression analysis was performed and the results are expressed with +/- 3SD(fig 1).
Additive affect on VitD (RTT vs SST): Whole blood was collected from two volunteers in red to (no additive) and SST collection tubes, centrifuged,and then were allowed to sit at 4 C for up to 19 days. Aliquots were taken at T=0, 2, 5, 6, 8, 12 and 19 days respectively and analyzed for [OHD3and OHD2]. Each sample was injected in duplicate and the results were averaged and expressed in ng/mL (fig. 2)
Hemolysis interference assay: Increasing amounts of RBC hemolyzates were added pooled serum to give final hemoglobin concentrations of0.0, 0.2, 1.2, 2.3, 4.6, 6.9 and 11.6 g/dL. Aliquots of each sample were then taken and analyzed. The 0.0 g/dL hgb sample was designated as100% and the remaining samples were normalized to this and the results were expressed as % recovery. Linear regression analysis wasperformed and the results are expressed with +/- 2 SD (fig. 3).
IntroductionVitamin D is a prohormone that is essential for normal calcium homeostasis and bonedevelopment. Deficiency in vitamin D leads to hypocalcemia and hypophosphatemia,with resultant rickets in children and osteomalacia in adults (1-2). In adults, vitamin Ddeficiency has been linked to cardiovascular disease, insulin resistance, hypertensionand other conditions. With the well-documented worldwide prevalence of vitamin Ddeficiency in all ages the volume of testing has increased dramatically over the recentpast. Thus, in effort to improve the efficiency of our laboratory and decrease the pre-analytic error associated with vitamin D testing we embarked on this study. Specifically,we addressed the following three objectives:
-Is 25-OH vitamin D stable under ambient (RT) conditions- Is 25-OH vitamin D stable when exposed to fluorescent light- Is 25-OH vitamin D stability affected by additives such as the gel in SSTs- Does hemolysis interfere with 25-OH vitamin analysis
Materials and Methods continued
Samples: Serum from study volunteers or from left over clinical samples were utilized forthese studies.
Internal standards (IS): Hexa-deuterated OHD2 and OHD3 (OHD2d6 and OHD3d6) wereobtained from Medical Isotopes, Inc.
Calibrators: Calibrators were prepared in 3% albumin at 5, 10, 20, 50, 100, and 150 ng/mLfor each analyte (OHD2 and OHD3).
Sample preparation: Samples and calibrators (500 ul) were spike with 75 ng IS, extractedin 1 ml of acetonitrile (ACN) and centrifuged. Thirty ul of the supernatant was theninjected into a Shimdazu HPLC at 70% H2O:30% ACN at 350 ul/min flow. Analytes wereseparated on a C18 column (50 mm x 2.1 mm x 3 micron, RESTEK) and then introducedinto a triple quadrupole mass spectrometer (ABI 3200 Q-Trap) via an APCI source inpositive ion mode. The analytes were eluted at 100% ACN over 9.7 minutes.
OH-Vit D (OH-D3) Stability RTT vs. SST. (T= 4C)
Effect of hemolysis on 25 OH Vit D recoveryVitamin D (OH-D3) recovery after storage(RTT, RT, + fluorescent light)
It is well known that vitamin D physiology and metabolism is dependent on UV light exposure. And perhaps this principle perpetuated some of the laboratory protocols regarding the collection and subsequent handling of samples for vitamin D analysis. Our laboratory used to require wrapping the collection tubes in aluminum foil and transferring serum into dark brown sample tubes. These protocols, due to excessive sample handling, may increase the risk of pre-analytic error. In this study we have addressed several parameters (temperature, storage conditions and collection tube additives) to determine whether or not vitamin D (25-OH vit D) is as unstable as once believed.
Based on this study we conclude that:-25-OH vitamin D is stable under ambient (RT) conditions-25 OH vitamin D is stable when exposed to fluorescent light-25-OH vitamin D is not affected by the gel additive in serum separator tubes (SST)-Hemolysis up to 2.3 g/dL does not affect the analysis of 25-OH vitamin D using our In-house LC-MSMS method. Considering clinical samples are typically rejected when gross hemolysis is detected (0.5 g/dL) this result indicates that any degree of hemolysis accepted by a clinical laboratory will be acceptable for our 25-OH vitamin D analysis.
Figure 1. Figure 2. Figure 3.
PUBLICATIONS Journal of Forensic Sciences. 2010 November; 55 (6): 1638 – 40. An unusual death involving a sensory deprivation tank. Lann MA, Martin A.
National Association of Medical Examiners Accreditation
In 2000, the Denver Office of the Medical Examiner received accreditation by NAME for the facility. Every five years the office has applied for accreditation and
on December 10, 2010 the office received its third accreditation. This accreditation recognized that the Denver Office of the Medical Examiner had achieved consistent performance and competency in medicolegal death
investigation, and is in compliance with standards developed by NAME. Only a handful of ME/Coroner offices in the country hold this accreditation.
FT. LOGAN NATIONAL CEMETERY This cemetery is located in the southwest area of Denver, Colorado
Fort Logan features a memorial pathway lined with a variety of memorials that honor America’s veterans from various organizations. There are 17 memorials at Fort Logan National Cemetery—most
commemorating soldiers of various 20th‐century wars.
PERFORMANCE MEASURES 2010 2010 Identification
and Notification of Next of Kin within 24 hours
Autopsy Reports completed within 60 days
All Reports Completed within 60 days (NAME target 90%)
All Reports completed within 90 days (NAME target 90%)
Bodies ready for release to mortuary within 48 hours
Non‐Autopsy cause and manner of death certificates provided within 10 days
Success 88% 70% 73% 92% 92% 84%
NAME requirements for report turnaround are above. Failure to achieve the ≤60 days is a Phase I deficiency (up to 15 allowed). Failure to achieve the ≤90 days is a Phase II deficiency (none allowed). The other metrics are internally chosen.
The National Association of Medical Examiners has developed case workload for physician workload. Physicians MUST keep workload levels less than 325 cases per physician in order to remain in compliance with NAME accreditation. Less than 250 cases is considered optimal. Caseload is defined as the sum of autopsies performed + the number of other non‐autopsy examinations using a ratio of 3‐5= 1 autopsy. NAME recognizes that physicians with additional administrative duties need to handle a smaller caseload. In addition, training fellows are considered one half of a full‐time pathologist; their cases are counted as one half credit for the fellow and one half credit for the attending pathologist. It is a phase I deficiency for each physician over 250, and a phase II deficiency for each physician over 325; inspectors are given some discretion in interpreting caseload numbers. For 2010, OME physicians remain in compliance with NAME workload requirements, with two physicians barely topping the ideal caseload number.
ANNUAL STATISTICAL REPORT 2010 TOTAL DEATHS REPORTED (All jurisdictions) 3291 Medical Examiner Cases (Jurisdiction Retained) 1032 Waived Cases (Jurisdiction Waived) 1579 ( Waived Natural Deaths ) 1314 ( Waived Transferred Jurisdiction ) 262 Waived – Declined/Other 3 Inquiries (No jurisdiction determined) (Declined – 2) (Request for Assistance ‐ 39) (Natural – 639)
680
Manner of death (ME Cases) 1033 Accident 297 Homicide 41 Suicide 104 Traffic Accidents 54 Undetermined 43
Request for assistance (non‐human bones, skeletal remains, reported asystolic deaths, outside agency assist requested etc.)
7
Natural 487Scene visits by ME or ME Investigators 736Bodies transported to office by order of DOME 879External examinations 211Complete autopsies 673Partial autopsies 0Outside autopsy for other jurisdiction 2Chart Review 153Hospital/private autopsies retained under the ME jurisdiction 2Cases where toxicology is performed 606Bodies unidentified after examination 0Organ and tissue releases 104 Percent 100%Unclaimed bodies (Coroner rotation burials) 18Exhumations 0
The Denver Office of the Medical Examiner has four main classifications of death investigations:
• ME or Medical Examiner cases o The Office of the Medical Examiner retains primary jurisdiction as
spelled out in Colorado Revised Statutes. Such cases have an in‐depth investigation and an Office of the Medical Examiner physician will certify the cause and manner of death.
• W or Waived cases o After initial investigation, some cases that are reportable by law
and/or Office of the Medical Examiner reporting policies may be transferred to another county (if the event resulting in death occurred outside Denver) or released to a hospital or treating physician to certify the death. The Office of the Medical Examiner has no further activity.
• I or Inquiry cases o Care facilities often report deaths which do not fall into the area of a
reportable death after evaluation of the circumstances of the death. These cases are totally released after this is documented.
• OC or Outside cases o In 2010, the Denver Office of the Medical Examiner began performing
autopsies for other Colorado counties for a fee.
TOTAL DEATHS REPORTED TO THE DENVER OFFICE OF THE MEDICAL EXAMINER 2010
ACCEPTED (ME) Medical Examiner Case; jurisdiction retained
1033 (31%)
WAIVED (W) Reported/Investigated and Released
1579 (48%)
NOT ACCEPTED (I) Reported to office, documented, and released
680 (21%)
OUTSIDE CASES (OC) Autopsy performed at the request of outside jurisdiction
2 (0%)
Total Deaths Reported to DOME
ME Cases, 1033, 31%
Waived Cases, 1579, 48%
Inquiries, 680, 21%
Outside Cases, 2, 0%
2009 vs 2010 ME cases
0
20
40
60
80
100
120
Num
ber
2009 ME 106 94 101 99 82 70 67 101 89 89 97 942010 ME 96 68 82 86 100 65 82 78 94 110 92 82
Jan Feb March April May June July Aug Sept Oct Nov Dec
The above table graphically depicts the month to month variation in jurisdictional cases handled by OME. Data from both 2009 and 2010 are included to allow for comparison over multiple years. Trend lines have also been added to show that trends are relatively stable although the trend in 2009 was for a slight decline over the year, while in 2010 there was a slight increase by the end of the year in ME cases.
CAUSE OF DEATH refers to the disease or injury that sets into motion the chain of events that result in death. Causes could be from a medical condition such as coronary artery disease, or a traumatic event such as gunshot wound. MANNER OF DEATH refers to how people die. There are five manners of death: Homicide (death caused by the actions of another), Suicide (death caused by intentional harm to self), Accident (death caused by non‐intentional injury); Natural (death due to a natural disease process), and Undetermined (could not assign other manner due to unclear of unknown circumstances). In general, if a non‐natural action has a contribution to the death, it will determine the manner. OME includes an additional “manner”, “request for assistance”, that includes bones cases and other activities that do not fit neatly into the other manners. TYPES OF EXAMINATIONS The Denver Office of the Medical Examiner constantly strives to balance best practices in death investigation with cost effectiveness and efficiently utilizing shrinking resources. In cases that the Office of the Medical Examiner retains jurisdiction, one of three medical examinations will occur.
• Autopsy – The examination of a deceased person to help determine the cause and manner of death, in addition to document injuries and disease processes, collect evidence, assist in identification, and preserved blood/tissue samples for future analysis. It includes an examination of written documents including medical records, examination of the body externally, and opening the head, neck, chest, and abdomen at a minimum, removing and thoroughly examining the organs. A report is compiled, which is a public record in Colorado.
• External examination – This includes the first two steps as an autopsy case, but the body is not surgically opened. Blood/fluid or other samples are still preserved when possible.
• Chart review – When a person dies of injuries that result in extensive medical treatment that is well documented, the body is not examined, but the cause of death is certified based upon review of medical records.
W cases have been steadily increasing over the past two years, although again there is fluctuation month‐to‐month. One explanation for this increase could be the increase in home hospice deaths. Again, although month‐to‐month variations occur, overall the number of I cases over the last two years has remained fairly steady with only a slight increase from the prior year.
2009 vs. 2010 W cases
0
20
40
60
80
100
120
140
160
Num
ber
2009 W 92 91 118 98 106 113 93 109 107 131 131 127
2010 W 126 132 136 121 131 113 113 123 145 143 142 147
Jan Feb March April May June July Aug Sept Oct Nov Dec
2009 vs. 2010 I cases
0
10
20
30
40
50
60
70
80
num
ber
2009 I 66 39 52 48 46 50 60 46 55 51 50 52
2010 I 46 55 52 51 70 70 60 50 51 50 51 62
Jan Feb March April May June July Aug Sept Oct Nov Dec
2010 DENVER OFFICE OF THE MEDICAL EXAMINER CASE DISTRIBUTION
Total ME Cases by Manner of Death
Undetermined, 43, 4%
Natural, 487, 47%
Traffic Accidents, 54, 5%
Suicide, 104, 10%
Homicide, 41, 4%
Accident (non-traffic), 297, 29%
Request for Assistance, 7, 1%
MEDICAL EXAMINER CASES ACCEPTED BY MANNER 2010
Natural Deaths 487
Accident (non‐traffic) 297Homicides 41Suicides 104Traffic Accident 54Undetermined 43Request for Assistance 6
487 (47.18%)297 (28.77%)41 (3.97%)
104 (10.07%)
54 (5.23%)43 (4.16%)
6 (0.67%)
Natural Deaths
Accident (non-traffic)Homicides
SuicidesTraffic Accidents
UndeterminedRequest for Assistance
ME Cases Accepted By Manner
NATURAL DEATH ALL ME CASES, BY EXAMINATION AND RACE
Category White Black Hispanic AsianNative
AmericanOther/
Unidentified Race TotalAutopsies 166 41 53 3 4 1 268External Examinations 125 34 23 2 2 0 186Initial External & Later Autopsy 0 1 1 0 0 0 2Chart Reviews 21 5 4 0 0 1 31Total 312 81 81 5 6 2 487
Natural Deaths by Examination and Race
Black15%
Hispanic20%
White63%
Asian 1%
Other 0
%
Native American
1%
NATURAL DEATHS BY AGE AND SEX ALL MEDICAL EXAMINER CASES 2010
Age Male Female TOTAL
0‐10 years 4 4 811‐20 years 2 0 221‐30 years 9 3 1231‐40 years 20 11 31
41‐50 years 40 16 5651‐60 years 87 36 12361‐70 years 73 26 99
71‐80 years 54 29 8381‐90 years 27 32 5991 + years 5 9 14TOTAL 321 166 487
Natural Deaths By Age and Sex
40
311
16
29
9
7387
52720
4 2 9
54
32
26
4 0
36
0-10years
11-20years
21-30years
31-40years
41-50years
51-60years
61-70years
71-80years
81-90years
91 +years
Male Female
NATURAL DEATH ALL ME CASES, BY CATEGORY and RACE
Category White Black Hispanic AsianAmerican
Indian Other TOTALCardiovascular 187 50 35 3 3 1 279Complications of ETOH 35 2 15 1 1 0 54Metabolic/Diabetes 11 5 6 0 1 0 23Respiratory/COPD 34 6 9 0 0 0 49Infectious Disease 13 4 3 0 0 0 20Neoplastic 14 8 2 0 1 0 25Other 19 6 10 1 0 1 37TOTAL 313 81 80 5 6 2 487
0 50 100 150 200
Cardiovascular
Complications of ETOH
Metabolic/Diabetes
Respiratory/COPD
Infectious Disease
Neoplastic
Other
Natural Deaths by CATEGORY and RACE
White Black Hispanic Asian American Indian Other
NATURAL DEATH ME Cases by AGE and RACE
Age White Black Hispanic Asian American Indian Other TOTAL0‐10 years 1 5 1 0 0 1 811‐20 years 0 1 0 0 1 0 221‐30 years 10 0 1 1 0 0 1231‐40 years 16 5 7 0 3 0 3141‐50 years 33 8 13 2 0 0 5651‐60 years 81 20 22 0 0 0 12361‐70 years 60 19 19 0 1 0 9971‐80 years 53 17 11 0 1 1 8381‐90 years 49 4 5 1 0 0 5991 + years 10 2 1 1 0 0 14TOTAL 313 81 80 5 6 2 487
Natural Deaths By AGE and RACE
0
20
40
60
80
100
White Black Hispanic Asian AmericanIndian
Other
Age
0-10 years 11-20 years 21-30 years 31-40 years 41-50 years51-60 years 61-70 years 71-80 years 81-90 years 91 + years
Natural Deaths by CATEGORY And SEX, Autopsy Cases Only
37.1%
13.7%8.1%
2.9% 2.2% 3.3% 2.6%5.2%
12.2%
3.7% 4% 2.9%0% 1.4%
CARDIOVASCULAR
COMPLICATIONS OF ETOH
RESPIRATORY
INFECTIOUS DISEASE
NEOPLASTIC
METABOLIC/DIABETES
OTHER
MaleFemale
NATURAL DEATHS BY CATEGORY/SEX AUTOPSY CASES ONLY
CATEGORY Male Female TotalASCVD, NOS 61 17 78Myocardial Infarction/CAD 6 1 7Stroke 7 6 13HTN 10 5 15Aortic Aneurysm 5 1 6Berry Aneurysm 0 0 0Cardiomyopathy 6 3 9Myocarditis 0 0 0Other 5 0 5TOTAL CARDIOVASCULAR 100 33 133 COMPLICATIONS OF ETOH 37 10 47 COPD & Emphysema 9 2 11Interstitial Lung Disease 0 1 1Asthma 1 2 3Pulmonary Embolus 6 4 10Pneumonia/Bronchitis 5 1 6Other 1 1 2TOTAL RESPIRATORY 22 11 33 Pneumonia 6 4 10Meningitis/Encephalitis 0 0 0TB 1 0 1HIV/AIDS 0 0 0Other 1 0 1TOTAL INFECTIOUS DISEASE 0 4 4 NEOPLASTIC 6 0 6METABOLIC/DIABETES 9 4 13OTHER 7 14 21 TOTAL ALL 189 80 269
Undetermined Manner of Death 2010 Undetermined manner is used to designate that a death does not fit the category of natural, suicide, homicide, or accident. This includes areas where the cause of death may have been found but the manner may not be clear. This may be due to a lack of background information, uncertainties in circumstances, or decomposition of the body related to a time delay in discovery. Decomposition can sometimes be a factor, as this can distort the body and render postmortem toxicology and other testing difficult to perform and/or interpret. There are also cases where the cause of death itself cannot be determined, again possibly related to advanced decomposition of the body or the inability to obtain sufficient information for a variety of reasons.
CAUSE OF DEATH Toxin Trauma Unknown/Other SUDI TOTALAutopsy 9 7 19 5 40External Exam 0 0 1 0 1Chart Review 0 1 1 0 2TOTAL 9 8 21 5 43
Undetermined Manner of Death 2010
Autopsy, 40, 93%
Chart Review, 2,
5%External
Exam, 1, 2%
Undetermined Manner of Death by METHOD
9, 22%
7, 18%19, 47%
5, 13%
Toxin Trauma Unknown/Other SUDI
UNDETERMINED BY AGE and SEX Age Male Female TOTAL0‐10 years 5 6 1111‐20 years 1 0 121‐30 years 2 0 231‐40 years 5 1 641‐50 years 7 3 1051‐60 years 5 4 961‐70 years 1 0 171‐80 years 0 2 281‐90 years 0 0 091 + years 0 0 0Unknown age/sex 1TOTAL 26 16 43
Undetermined by AGE and SEX
1
5
1
5
2
7
5
1
0 0 0
6
0 0
3
4
0
2
0 0
0-10years
11-20years
21-30years
31-40years
41-50years
51-60years
61-70years
71-80years
81-90years
91 +years
Uknownage/sex
Male Female
UNDETERMINED BY AGE and METHOD
Age Toxin TraumaUnknown/
Other SUDI TOTAL TOTAL % BY AGE
0‐10 years 1 1 5 5 12 27.911‐20 years 0 1 0 0 1 2.321‐30 years 0 2 0 0 2 4.631‐40 years 1 0 5 0 6 13.941‐50 years 4 1 5 0 10 23.251‐60 years 3 2 4 0 9 20.961‐70 years 0 0 1 0 1 2.371‐80 years 0 1 1 0 2 4.681‐90 years 0 0 0 0 0 091 + years 0 0 0 0 0 0TOTAL 9 8 21 5 43 TOTAL % BY METHOD 20.9 18.6 48.8 11.6
00.5
11.5
22.5
33.5
44.5
5
Toxin Trauma Unknown/Other SUDI
Undetermined by AGE and METHOD
0-10 years 11-20 years 21-30 years 31-40 years 41-50 years51-60 years 61-70 years 71-80 years 81-90 years 91 + years
UNDETERMINED BY AGE and RACE
Age White Black Hispanic AsianAmerican
Indian Other Unknown TOTAL0‐10 years 4 4 3 0 0 0 1 1211‐20 years 1 0 0 0 0 0 0 121‐30 years 1 0 1 0 0 0 0 231‐40 years 3 2 1 0 0 0 0 641‐50 years 5 3 0 0 2 0 0 1051‐60 years 6 1 2 0 0 0 0 961‐70 years 0 1 0 0 0 0 0 171‐80 years 1 1 0 0 0 0 0 281‐90 years 0 0 0 0 0 0 0 091 + years 0 0 0 0 0 0 0 0TOTAL 21 12 7 0 2 0 1 43
0123456
0-10 years
11-20 years
21-30 years
31-40 years
41-50 years
51-60 years
61-70 years
71-80 years
81-90 years
91 + years
Undetermined by AGE and RACE
White Black Hispanic Asian American Indian Other Unknown
SUDDEN UNEXPECTED DEATHS IN INFANCY (SUDI) 2010 The Office of the Medical Examiner certifies sleep associated deaths in infants as undetermined in manner rather than natural, following evolving practice changes in the field of forensic medicine recognizing the uncertainties and multi‐factorial issues related to these deaths. In the past, these deaths might have been called "SIDS" or Sudden Infant Death Syndrome. More recent literature uses the term "Sudden Unexplained Death in Infancy" or SUDI. Recognized risk factors include external factors that could contribute to asphyxia in these children, for example bed sharing with an adult and unsafe sleep surfaces. OME feels these deaths are best certified as undetermined in manner for these reasons.
SUDI by AGE and SEX
Male 0 1 1 0 0Female 1 0 0 1 1
1 month 2 months 4 months 5 months > 6 months
SUDI by RACE and SEX
Hispanic 0 1Black 1 1White 1 1
Male Female
Morning (8:01 am
- 12:14 pm)Afternoon (12:15
pm - 6:00 pm)Evening (6:01pm - 8:00 am)
Female, 3Female, 0 Female, 0
Male, 0 Male, 0 Male, 2
SUDI By SEX and TIME OF DAY
SUDI By SEX and MONTH OF DEATH
1 11 1 1
January
February
March
April
May
June Ju
ly
August
September
October
November
December
MaleFemale
Violent crime nationwide has been decreasing and Denver is no exception. Since 2005, homicides in Denver have trended downward. According to 2010 census data, non‐Hispanic whites account for 52.2% of Denver's population. Hispanics account for 31.8% and blacks account for 10.2%. However, blacks and Hispanics are disproportionately represented as victims of homicide. In addition, males make up a disproportionate number of homicide victims in Denver at a ratio of approximately 9:1.
COLD CASES In 2004, the Denver Police Department was the recipient of a federal grant to help work up unsolved violent crimes such as homicide and sexual assault. With advances in DNA testing, OME has increasingly been enlisted to assist with working up these cases. As custodian of records, Michelle Weiss‐Samaras increasingly provides DPD with sources of DNA material and other investigative files to help solve these crimes.
homicides 2005-2010
0
10
20
30
40
50
60
70
homicides 60 60 56 55 48 41
2005 2006 2007 2008 2009 2010
Homicides by RACE and SEX
-5
0
5
10
15
Female 0 1 1 0 2 0Male 0 12 14 0 10 1
Race: Asian Black Hispanic American Indian White Other
10
4
1
9
2
11
0
5
0
4
010
2
0 0 10 0
0-10 years
11-20 years
21-30 years
31-40 years
41-50 years
51-60 years
61-70 years
71-80 years
81-90 years
91 + years
2010 Homicides by AGE and SEXMaleFemale
Homicides by RACE and SEX
-5
0
5
10
15
Female 0 1 1 0 2 0Male 0 12 14 0 10 1
Race: Asian Black Hispanic American Indian White Other
OME almost universally performs autopsies and victims of homicide. Rarely, there is a significant delay between injury and the death and all investigative and legal activities have been exhausted by the time the death occurs. In these situations, the pathologist reviewing the case may opt to perform a more limited examination. Drug and ethanol testing is performed on all homicide deaths where feasible e.g. where death occurs shortly after the injury was inflicted and/or in hospitalized individuals adequate antemortem blood samples can be obtained from the hospital. In this latter instance OME makes every effort to procure the earliest blood sample drawn at the hospital for this testing. These samples however are not always available and thus there are a certain number of cases where drug and ethanol testing is not possible. Drugs detected include both illicit and legally obtained drugs, both over‐the‐counter and prescription medications. Marijuana (THC) was the drug most commonly detective in OME homicide deaths. More than one drug was present in almost 20% of cases. Over half or 63% had at least one drug documented. 34% had ethanol present. In all of these victims the level was over the legal limit of greater than or equal to .08% as defined in Colorado statute. Sunday was the most likely day to die from homicide. Most victims were between
the ages of 21 and 40 years of age.
Homicides by SEX and RACE with DRUGS SEX RACE
DRUGS Male Female White Black Hispanic Asian American Indian Other TOTAL
Negative/Not Available 13 2 5 5 4 0 0 1 15Cocaine/Metabolites 3 0 0 1 2 0 0 0 3Heroin 0 0 0 0 0 0 0 0 0Methamphetamine 1 0 1 0 0 0 0 0 1THC 11 1 4 6 2 0 0 0 12Morphine 0 0 0 0 0 0 0 0 0LSD 0 0 0 0 0 0 0 0 0Pseudoephedrine 0 0 0 0 0 0 0 0 0Other 2 0 0 0 2 0 0 0 2Multiple Drugs 7 1 2 1 5 0 0 0 8TOTAL 37 4 41
Homicides by RACE with DRUGS
0
1
2
3
4
5
6
7
Whit
eBlac
k
Hispan
icAsia
n
America
n Ind
ianOthe
r
Negative/Not AvailableCocaine/MetabolitesHeroinMethamphetamineTHCMorphineLSDPseudoephedrineOtherMultiple Drugs
Homicides by SEX and RACE with ALCOHOL
Blood Alcohol SEX RACE
Male Female White Black Hispanic AsianAmerican
Indian Other TOTALNot Done/Negative 23 4 10 12 5 0 0 1 28Less than 0.050% 0 0 0 0 0 0 0 0 00.051% ‐ 0.1% 0 0 0 0 0 0 0 0 00.101% ‐ 0.150% 5 0 2 0 3 0 0 0 50.151% ‐ 0.2% 4 0 0 1 3 0 0 0 40.201% ‐ 0.25% 2 0 0 0 1 0 0 0 20.251% ‐ 0.3% 2 0 0 0 2 0 0 0 20.301% ‐ 0.350% 1 0 0 0 1 0 0 0 1> 0.351% 0 0 0 0 0 0 0 0 0TOTAL 37 4 41
Homicides by RACE involving Alcohol
0 2 4 6 8 10 12 14
Not Done/Negative
Less than 0.050%
0.051% - 0.1%
0.101% - 0.150%
0.151% - 0.2%
0.201% - 0.25%
0.251% - 0.3%
0.301% - 0.350%
> 0.351%
White Black Hispanic Asian American Indian Other
Homicides by Time of Day Female Male TOTALTime of Day 12:01 AM - 6:00 AM 1 15 166:01 AM - NOON 1 6 712:01 PM - 6:00 PM 1 6 76:01 PM - MIDNIGHT 1 10 11TOTAL 4 37 41
Homicides by Day of the Week
02468
1012
MaleFemale
Male 10 7 7 6 0 6 1Female 0 2 0 0 1 1 0
Sunday Monday Tuesday Wednesd Thursday Friday Saturday
Male6:01 PM ‐ MIDNIGHT,
10
12:01 PM ‐ 6:00 PM, 6
12:01 AM ‐ 6:00 AM, 15
6:01 AM ‐ NOON, 6
Female6:01 PM ‐ MIDNIGHT,
1
12:01 AM ‐ 6:00 AM, 1
6:01 AM ‐ NOON, 1
12:01 PM ‐ 6:00 PM, 1
Homicides by AGE and RACE
0
2
4
6
8
10
12
Other 0 0 0 0 1 0 0 0 0 0American Indian 0 0 0 0 0 0 0 0 0 0Asian 0 0 0 0 0 0 0 0 0 0Hispanic 0 2 4 6 2 0 1 0 0 0Black 0 2 5 3 0 2 0 1 0 0White 1 1 2 2 2 2 0 1 1 0
0-10 years
11-20 years
21-30 years
31-40 years
41-50 years
51-60 years
61-70 years
71-80 years
81-90 years
91 + years
Homicides by AGE and METHOD
0 2 4 6 8
0-10 years
11-20 years
21-30 years
31-40 years
41-50 years
51-60 years
61-70 years
71-80 years
81-90 years
91 + years
Sharp Force Injury 0 1 3 1 0 0 0 0 0 0GSW 0 4 6 7 4 3 1 1 1 0Combo/Other 0 0 0 2 0 1 0 0 0 0Blunt Injury 1 0 1 1 1 0 0 1 0 0Asphyxia 0 0 1 0 0 0 0 0 0 0
0-10 years
11-20 years
21-30 years
31-40 years
41-50 years
51-60 years
61-70 years
71-80 years
81-90 years
91 + years
Asph
yxia
Blun
t Inj
ury
Com
bo/O
ther
GSW
Shar
p Fo
rce
Inju
ry
Male, 1Female, 0
Male, 4
Female, 1
Male, 3Female, 0
Male, 24Female, 3
Male, 5Female, 0
Homicides by SEX and METHOD
0
10
20
30
40
Homicides - Examinations
Male 36 0 1
Female 4 0 0
Autopsies External Examinations Chart Review
Homicides by Setting and Sex
Female Male TOTALOut of State 0 0 0Resident of Another 1 6 7Residence 2 9 11Road 0 0 0Parking Lot (work) 0 0 0Alley 0 2 2Apartment 0 0 0Car 0 4 4Nightclub 0 0 0Field 0 0 0Outside Area 0 1 1Outside Home 1 3 4Outside Restaurant 0 0 0Inside Restaurant 0 0 0Parking Lot 0 1 1Public Place 0 0 0Sidewalk 0 2 2Store 0 1 1Street 0 3 3Unknown 0 3 3Workplace Site 0 1 1Yard 0 0 0Detention Facility 0 1 1TOTAL 4 37 41
Colorado has one of the highest suicide rates in the country. Denver’s suicide rate is approximately equal to the overall state rate.
Compared with past years, suicide deaths are trending upwards in Denver County.
A person may have one or more risk factors that would put an individual at increased risk for completing the suicide. In 2009, OME became more aggressive in tracking these risk factors and recording them in a way that they could be better tracks. These risk factors will be tracked over time to determine if there are any identifiable trends in risk factors.
Suicides 2005-2010
0
20
40
60
80
100
120
number of suicides 97 79 102 95 99 104
2005 2006 2007 2008 2009 2010
Fem
ale
Mal
e
AutopsyExternal
Exam
ChartReview
0 001
25
78
Suicide ‐ Examinations
Autopsy 25 78
External Exam 0 1
Chart Review 0 0
Female Male
TOTAL PERCENTAGE: 99.03% AUTOPSIES
0.96% EXTERNALS (Method – Hanging) 0% CHART REVIEWS
Suicides by AGE and RACE SUICIDES Year 2009 Race Female Male Total
Black 1 5 6 Hispanic 1 7 8 American Indian 0 0 0 White 19 63 82 Asian 1 2 3
0
5
10
15
20
25
White 0 2 12 13 20 20 7 0 3 0Black 0 0 2 2 2 2 2 0 0 0Hispanic 0 0 6 2 5 0 2 0 0 0Asian 0 0 0 0 0 0 0 0 0 0American Indian 0 0 0 0 1 0 0 0 0 0Other 0 0 1 0 0 0 0 0 0 0
0-10 years
11-20 years
21-30 years
31-40 years
41-50 years
51-60 years
61-70 years
71-80 years
81-90 years
91 + years
Suicide by SEX and MARITAL STATUS
7164
20
12
38
0
2
2
3
Female Male
WidowedUndeterminedSingleMarriedDivorced
Suicide by AGE and SEX
0
0
16
12
22
16
10
0
3
0
0
2
5
5
6
5
2
0
0
0
0-10 years
11-20 years
21-30 years
31-40 years
41-50 years
51-60 years
61-70 years
71-80 years
81-90 years
91 + years
MaleFemale
SUICIDES BY METHOD AND AGE
Alcohol Gunshot HangingJumped
from Height OtherOverdose/
Toxic Sharp Force TOTAL
Age
0‐10 years 0 0 0 0 0 0 0 0
11‐20 years 0 0 2 0 0 0 0 2
21‐30 years 0 6 8 1 3 3 0 21
31‐40 years 0 2 11 0 2 2 0 17
41‐50 years 0 4 10 2 1 11 0 28
51‐60 years 0 11 5 1 0 4 1 22
61‐70 years 0 7 3 0 0 1 0 11
71‐80 years 0 0 0 0 0 0 0 0
81‐90 years 0 2 0 1 0 0 0 3
91 + years 0 0 0 0 0 0 0 0
TOTAL 0 32 39 5 6 21 1 104
0 2 4 6 8 10 12
Alcohol
Gunshot
Hanging
Jumped from Height
Other
Overdose/Toxic
Sharp Force
Suicides by METHOD and AGE
0-10 years 11-20 years 21-30 years 31-40 years 41-50 years51-60 years 61-70 years 71-80 years 81-90 years 91 + years
SUICIDE INFORMATION / RISK FACTORS
Note Left 32Previous Threats/Attempts 48Prior Suicide in Family 3Loss of Loved One 11Financial 15Marital/Relationship Problems 31Illness/Self 23Legal/Disciplinary Problems 10Drug/Alcohol Problems 38Unknown/Multiple Factors 6
Suicide Information-Risk Factors
15%
21%
1%5%
7%14%
11%
5%
18%
3%
Note Left
PreviousThreats/AttemptsPrior Suicide in Family
Loss of Loved One
Financial
Marital/RelationshipProblemsIllness/Self
Legal/DisciplinaryProblemsDrug/Alcohol Problems
Unknown/MultipleFactors
05
10
15
20
Suicides by Days of the Week
Female 4 4 4 4 4 1 4Male 8 10 17 12 9 13 10
Sunday Monday Tuesday Wednesday Thursday Friday Saturday
Suicides by Time of Day
0
5
10
15
20
25
30
Female 1 6 10 8
Male 6 23 24 26
12:01 AM - 6:00 AM 6:01 AM - NOON 12:01 PM - 6:00 PM 6:01 PM - MIDNIGHT
Suicide Settings
Female Male TOTALAlley 1 1 2Assisted Living Facility 0 1 1Bus Station 0 1 1Car 2 2 4Cellar 0 1 1Detention Facility/Jail 1 3 4Detox Center 0 1 1Garage 1 8 9Group Home 0 1 1Highway/Roadway 1 1 2Hotel/Motel 2 6 8Other's Residence 0 2 2Outside Home/Apartment 0 3 3Outside Other's Home/Apartment 0 1 1Parking Garage 1 1 2Religious Facility (Inside or Outside) 0 1 1Residence/Home 15 42 57Residence/Apartment 1 1 2Train/Light Rail Tracks 0 2 2TOTAL 25 79 104
DRUG RELATED DEATHS 2004 THROUGH 2010
DENVER OFFICE OF THE MEDICAL EXAMINER IN CONJUNCTION WITH THE DENVER OFFICE OF DRUG STRATEGY (DODS)
In 2008, OME partnered with the Denver Office of Drug Strategy to gather data on drug‐related fatalities in Denver from 2003 to present. The compilation of data is part of a bigger work group, which brings representatives from law enforcement, OME, DODS, Denver Police Crime Laboratory, Rocky Mountain Poison and Drug Center, Denver Health and Hospitals, and several drug abuse treatment providers. This workgroup will continue to examine drug use/abuse trends and determine effectiveness of treatment and prevention efforts. OME would like to thank Bruce Mendelson, senior data consultant for the DODS, for his tireless work in pulling out the mortality data.
2004 – 2010 Drugs Contributing to Cause of Death
Including Accidents, Suicides, and Undetermined Manner 2004 2005 2006 2007 2008 2009 2010 n % n % n % n % n % n % n % Cocaine 58 38.4 82 48.2 85 50.3 75 39.7 60 8.3 53 25.6 41 27Morphine 57 37.7 60 35.3 64 37.9 43 22.8 48 22.6 26 12.6 18 11.8Alcohol 60 39.7 44 25.9 65 38.5 66 34.9 75 35.4 72 34.8 52 34.2Codeine 25 16.6 36 21.2 36 21.3 18 9.5 19 9.0 11 5.3 3 2.0Heroin 6 4.0 18 10.6 17 10.1 18 9.5 27 12.7 49 23.7 35 23Methadone 43 8.6 17 10.0 16 9.5 14 7.4 15 7.1 15 7.2 11 7.2Oxycodone 6 4.0 12 7.1 7 4.1 38 20.1 33 15.6 48 23.2 24 15.8Methamphetamine 7 4.6 12 7.1 9 5.3 12 6.3 15 7.1 10 4.8 14 9.2Acetaminophen 9 6.0 11 6.5 2 1.2 14 7.4 13 6.1 4 1.9 8 5.3Diazepam 11 7.3 10 5.9 11 6.5 19 10.1 16 7.5 23 11.1 19 12.5Alprazolam 3 2.0 10 5.9 5 3.0 13 6.9 15 7.1 20 9.7 12 7.9Hydrocodone 4 2.6 7 4.1 10 53.9 8 4.2 22 10.4 18 8.7 10 6.6Diphenhydramine 2 1.3 7 4.1 1 0.6 11 5.8 11 5.2 3 1.4 9 5.9Clonazepam 0 0 2 1.2 0 0 1 .5 4 1.9 8 3.9 7 4.6Fentanyl 2 1.3 3 1.8 3 1.8 5 2.6 5 2.4 13 6.3 5 3.3Decedents* 151 170 169 189 212 207 152Source: Denver Medical Examiner’s Office Autopsy Reports * Drug totals won’t sum to decedents because more than one drug may be found in individual’s toxicology
2004-2010 Drugs Contributing to Cause of DeathIncluding Accidents, Suicides, and Undetermined
020406080
100
2004 2005 2006 2007 2008 2009 2010
Cocaine Morphine Alcohol CodeineHeroin Methadone Oxycodone MethamphetamineAcetaminophern Diazepam Alprazolam HydrocodoneDiphenhydramine Clonazepam Fentanyl
Accidents - Examinations
0
20
40
60
80
100
120
140
Autopsies 18 19 3 1 126 9External Examination 2 3 0 0 3 2Chart Review 4 101 0 0 3 3
Asphyxia/drowning Falls Fire Motor
VehicleOverdose
/toxic Other
Accidents by CATEGORY and AGE
0
1020
30
4050
60
Asphyxia/drowning 6 0 1 2 5 5 0 3 2 0Falls 1 1 1 1 7 7 8 21 52 24Fire 0 0 0 0 0 2 1 0 0 0Motor Vehicle 0 0 0 1 0 0 0 0 0 0Overdose/toxic 0 1 25 33 39 27 6 1 0 0Other 0 0 1 0 3 5 0 2 2 1
0-10 years
11-20 years
21-30 years
31-40 years
41-50 years
51-60 years
61-70 years
71-80 years
81-90 years
91 + years
020406080
100
Accidents by CATEGORY and SEX
Male 14 63 1 1 95 8Female 10 60 2 0 37 6
Asphyxia/drowning Falls Fire Motor
VehicleOverdose/
toxic Other
Accidents by SEX and MARITAL STATUS
Common Law
Divorced
Married
Single
Unknown
Widowed
Female 0 23 27 20 5 40Male 1 33 48 69 9 22
Common Law Divorced Married Single Unknown Widowed
Accidents by SEX and AGE
Male Female TOTAL0‐10 years 4 3 711‐20 years 1 1 221‐30 years 21 7 2831‐40 years 27 10 3741‐50 years 40 14 5451‐60 years 31 15 4661‐70 years 9 6 1571‐80 years 15 12 2781‐90 years 27 29 5691 + years 7 18 25TOTAL 182 115 297
43
11
21
7
27
10
40
14
31
15
96
15
1227
29
7
18
0-10years
11-20years
21-30years
31-40years
41-50years
51-60years
61-70years
71-80years
81-90years
91 +years
Accident by SEX and AGE
FemaleMale
Accidents by AGE and RACE
Asian Black Hispanic American Indian White Other TOTAL0‐10 years 0 4 2 0 1 0 711‐20 years 0 0 0 0 2 0 221‐30 years 0 2 5 1 20 0 2831‐40 years 0 4 3 1 29 0 3741‐50 years 0 3 14 1 36 0 5451‐60 years 0 7 7 0 32 0 4661‐70 years 0 2 2 1 10 0 1571‐80 years 0 2 6 0 19 0 2781‐90 years 2 3 2 0 48 1 5691 + years 1 1 1 0 22 0 25TOTAL 3 28 42 4 219 1 297
Accidents by RACE and AGE
0102030405060
0-10years
11-20years
21-30years
31-40years
41-50years
51-60years
61-70years
71-80years
81-90years
91 +years
Asian Black Hispanic American Indian White Other
Accidents by Setting and Sex
Male Female TOTALAlley 4 0 4Assisted Living/Nursing Home 14 22 36Auditorium 1 0 1Baseball Park 0 1 1Bus/Bus Stop 1 1 2Business/Store/Restaurant 4 1 5Car 2 1 3Daycare 1 0 1Garage 1 0 1Halfway House 1 0 1
Health Care Facility/Hospital 5 2 7Highway/Roadway 2 0 2Hospice 0 1 1Hotel/Motel 9 2 11Other's Residence 4 3 7Outside Area/Park 5 1 6Outside Business 1 1 2Outside Home/Apartment 5 2 7Parking Lot 5 1 6Playground 1 0 1Pool 1 0 1Rehabilitation Facility 1 0 1Residence/Home 83 66 149Residence/Apartment 3 1 4River/Lake 4 0 4Sidewalk 1 1 2Ski Resort 1 1 2Social Club 1 0 1Street 2 0 2Train/Light Rail Tracks 1 0 1Unknown 16 7 23Vacant Building/Resident 2 0 2TOTAL 182 115 297
ta
3612
1230
Traffic Accidents - Examinations
Autopsy 30 12External Examination 2 1
Chart Review 6 3
Male Female
TOTAL PERCENTAGE:
73.91% AUTOPSIES 8.7% EXTERNALS 17.39% CHART REVIEWS
0 10 20 30 40
Male
Female
Chart Review 6 3
External Examination 2 1
Autopsy 30 12
Male Female
1
5
16
19
1
0
0
0
3
0
2
7
0
0
0Asian
Black
Hispanic
White
Other
Autopsy 1516191
External Examination 00030
Chart Review 00270
AsianBlackHispanicWhiteOther
TRAFFIC FATALITIES by SEX and AGE
Male Female TOTAL0‐10 years 3 0 311‐20 years 6 1 721‐30 years 6 4 1031‐40 years 1 2 341‐50 years 5 2 751‐60 years 5 1 661‐70 years 1 3 471‐80 years 7 1 881‐90 years 4 2 691 + years 0 0 0TOTAL 38 16 54
Male
3
6
6
15
5
1
7
4 00-10 years11-20 years21-30 years31-40 years41-50 years51-60 years61-70 years71-80 years81-90 years91 + years
Female
0 1
4
22
1
3
1
2 00-10 years11-20 years21-30 years31-40 years41-50 years51-60 years61-70 years71-80 years81-90 years91 + years
Traffic Accidents by Time of Day
Male Female TOTAL12:01AM to 6:00 AM 9 5 1412:01 PM to 6:00 PM 5 11 166:01 AM to Noon 3 6 96:01 PM to Midnight 3 12 15TOTAL 20 34 54
Traffic Accidents by Days of the Week
0
5
10
15
Female 2 2 1 3 0 4 4
Male 11 3 3 3 6 5 7
Sunday Monday Tuesday Wednesday Thursday Friday Saturday
Male Female
12:01AM to 6:00 AM12:01 PM to 6:00 PM6:01 AM to Noon6:01 PM to Midnight
Vehicle Position – All Traffics
Male Female TOTALDriver 10 6 16Passenger 3 6 9Bicycle 2 0 2Pedestrian 10 1 11Unknown 0 2 2Moped 2 0 2Motorcycle 5 1 6Skate Board 1 0 1Struck by Lightning in vehicle 1 0 1Vehicle/Fixed object 4 0 4TOTAL 38 16 54
Toxicology Done: Total 28 tested for both drugs and alcohol. One drug screen only.
0
5
10
15
20
25
30
35
40
Male Female
Driver PassengerBicycle PedestrianUnknown MopedMotorcycle Skate BoardStruck by Lightning in vehicle Vehicle/Fixed object
AT FAULT DRIVERS Blood alcohol/drugs Totals No toxicology ordered 4 Negative 3 BAC Range 0 ‐ .204% 1 THC & Benzodiazepines 1 Opiates 1 Methamphetamine/Amphetamine 1Total At‐Fault Drivers 11 PEDESTRIANS Blood alcohol/drugs Totals No toxicology ordered 4 Negative 3 BAC Range 0 ‐ .357% 2 Alcohol & THC 1 Benzodiazepines & Opiates 1Total Pedestrian – Traffic Accidents 7 BICYCLISTS Blood alcohol/drugs Totals Negative 1 Alcohol & THC 1Total Bicyclist – Traffic Accidents 2
MOTORCYCLE Blood alcohol/drugs Totals No toxicology ordered 4 Negative (Drugs Only) 2 Negative (ETOH) 2 BAC Range 0 ‐ .220% 2 THC 1Total Motorcycle Accidents 11
0
2
4
6
8
10
12
14
Blood Alcohol by RACE
Not done/Not available 1 0 1 11 14 0Negative 0 0 4 3 10 0Less than 0.050% 0 0 0 0 2 00.051 - 0.100% 0 0 0 0 0 00.151 - 0.200% 0 0 0 2 3 00.201 - 0.250% 0 0 0 1 0 10.251 - 0.300% 0 0 0 0 0 00.301 - 0.350% 0 0 0 0 0 0> 0.351% 0 0 0 1 0 0
Asian American Indian Black Hispanic White Other
Blood Alcohol by SEX
0
2
4
6
8
10
12
14
16
18
Male 16 14 1 2 2 2 0 0 1Female 10 4 1 0 1 0 0 0 0
Not done/Not available
Negative Less than 0.050%
0.051 - 0.100%
0.151 - 0.200%
0.201 - 0.250%
0.251 - 0.300%
0.301 - 0.350% > 0.351%
Traffic Accidents, Detected Drugs by SEX and RACE
DRUGS SEX RACE TOTAL
Male Female White Black Hispanic AsianAmerican
Indian OtherNot Done/Available 15 10 14 1 9 1 0 0 25
Not Significant/Negative 14 4 9 4 4 0 0 1 18Methamphetamine
/Amphetamine 0 1 0 0 1 0 0 0 1THC 4 1 3 0 2 0 0 0 5
Morphine 1 0 1 0 0 0 0 0 1Multiple Drugs 4 0 2 0 2 0 0 0 4
TOTAL 38 16 29 5 18 1 0 1 54
Male
Female
4
01
0
4
10
1
14
4
15
10
Detected Drugs by SEX
Not Done/AvailableNot Significant/NegativeMethamphetamine/AmphetamineTHCMorphineMultiple Drugs
Detected Drugs by RACE
14
1
9
1
9
4 4
11
32
12 2
0
White Black Hispanic Asian AmericanIndian
Other
Not Done/Available
Not Significant/Negative
Methamphetamine/Amphetamine
THC
Morphine
Multiple Drugs
Denver has a diverse cultural composition, and continues to grow in population; Growth is comprised of a spectrum of racial and ethnic groups represented. The Denver Office of the Medical Examiner feels it is particularly important to be sensitive to others and respects, and appreciates all cultures and religious beliefs. If an autopsy is required, the office strives to adhere to as many cultural and religious beliefs as possible, though the office must complete its statutory duty and determine the cause and manner of death. The office continually strives to help the friends and families understand the duties of the office and the need for our involvement in the investigation of the death of their loved one. Contact with clergymen is encouraged, when appropriate and attempts are made to locate a professional that is bilingual when needed. While there are no Colorado State Laws which require the Coroner/Medical Examiner to identify and locate next of kin, this office has historically been tasked with this job. The Medical Examiner’s Office has been involved in the training of the Victim Advocates for years and is fortunate to have the assistance of the Denver Police Department Victim Advocates to assist when possible in the notification of the next of kin.
The City of Denver has over 200 city and mountain parks. Many events are held for the public in these parks. Many of the Parks have rivers, lakes, and trails for walking, riding bikes, and running, for the public enjoyment. Though the City of Denver owns many mountain parks outside of Denver proper, this office does not respond to deaths in these mountain areas. The local law enforcement and Coroner have the authority to handle those deaths for the Denver Office of the Medical Examiner.